Same Labmates, Different Projects

In 1990 Susumu Tonegawa, winner of the 1987 Nobel Prize in physiology or medicine, decided that he'd like to make something of a career change. Tonegawa, who won for his findings on the mechanism of antibody diversity and antigen recognition, chose to move away from his vocation as an immunologist and pursue a longtime fascination with neuroscience. He sought, in effect, to shift the focus of his entire lab. Nine years later, the conversion is complete: Tonegawa recently sent out his last

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In 1990 Susumu Tonegawa, winner of the 1987 Nobel Prize in physiology or medicine, decided that he'd like to make something of a career change. Tonegawa, who won for his findings on the mechanism of antibody diversity and antigen recognition, chose to move away from his vocation as an immunologist and pursue a longtime fascination with neuroscience. He sought, in effect, to shift the focus of his entire lab.

Nine years later, the conversion is complete: Tonegawa recently sent out his last immunology graduate student. But how did he and his immunologist labmates garner the know-how and tools necessary to make the switch? And how did these neuroscience newcomers, seemingly starting from scratch, gain the respect of their neuroscientist peers?

The research team includes, clockwise from left, Arvind Govindarajan, Tom McHugh, Susumu Tonegawa, and Chanel Lovett. The key, says Tonegawa, a Howard Hughes Medical Institute investigator and director of Massachusetts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies